
Aspen bags Covid-19 vaccine deal
Loading player...
Aspen Pharmacare has reached a preliminary agreement with Johnson & Johnson to manufacture the US company's Covid-19 vaccine should its clinical trials prove successful. The production will be done at Aspen's Port Elizabeth facility. Business Day TV spoke to the drugmaker's CEO Stephen Saad for more detail on the agreement and what it could potentially mean for the company's growth prospects.





